Clinical Trials Logo

Clinical Trial Summary

To evaluate the relation between thyroid, parathyroid hormones and estimated glomerular filtration rate in chronic kidney disease .


Clinical Trial Description

CKD is defined as abnormalities of kidney structure or function, present for >3 months, with implications for health. CKD is classified based on Cause, GFR category (G1-G5), and Albuminuria category (A1-A3) . The global prevalence of CKD is 13.4%, with 10.6% being stages 3-5 ,Over the past 10 years, the death rate due to CKD has increased by 31.7% . CKD patients remain sometimes asymptomatic, presenting the complications typical of renal dysfunction only in more advanced stages. Its treatment can be conservative usually in patients with glomerular filtration rate above 15 ml/minute without indications of dialysis or replacement therapy . In CKD patients the changes of endocrine system levels may arise from several causes as the kidney is the site of degradation & synthesis of many different hormones . So thyroid and parathyroid hormones dysfunction has been recognized as common co-morbidity that is often diagnosed with CKD . Thyroid hormone is one of the most important hormones in the human body as it regulates majority of the body's physiological actions . Parathyroid hormone (PTH) is one of the most important hormones required for the maintenance of calcium and phosphate homeostasis . Chronic kidney disease metabolic bone disorder (CKD-MBD) among patients with end stage renal disease ranges from 33% to 67%, and its severity tends to increase with the progression of the kidney damage & high mortality rates . CKD-MBD causes bone abnormalities that affect turnover, volume, mineralization, vascular, linear growth, and density, and soft tissue calcification . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05243979
Study type Observational
Source Assiut University
Contact Sara Magdy
Phone 01098777997
Email dr.sara54.sm@gmail.com
Status Not yet recruiting
Phase
Start date March 1, 2022
Completion date April 1, 2023

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04085913 - Exparel Injection Effect on Postoperative Opioid Usage Early Phase 1
Completed NCT04647006 - Comparison of TOETVA and Conventional Thyroidectomy N/A
Completed NCT04763122 - Thyroid Cancer in United Arab Emirates
Completed NCT05323539 - Comparison of Thyroid Volumes in Patients With and Without Endometrioma N/A
Recruiting NCT04160637 - Is There Benefit From Early Postoperative PTH Monitoring?
Completed NCT03597659 - PheWAS of a Polygenic Predictor of Thyroid Function
Completed NCT03430141 - A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer N/A
Recruiting NCT04115514 - Treatment of ARDS With Instilled T3 Phase 2
Recruiting NCT04623801 - Laser Ablation of Papillary Thyroid Microcarcinoma Phase 2
Recruiting NCT03754621 - Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
Withdrawn NCT03060499 - Post Thyroidectomy Myocardial Function
Completed NCT05276271 - The Effect of Levetiracetam on Lipid Profile in Children
Recruiting NCT04014660 - Prevention av Autoimmunitet Med Laktobaciller N/A
Completed NCT02304172 - The Efficacy and Safety of Thunderbeat in Thyroid Surgery N/A
Recruiting NCT04571736 - Pilot Study for Thyroid Surgery by Preoperative Video Support and Personalized and Secure Web Platform N/A
Recruiting NCT05510609 - Three-dimensional Ultrasonography Thyroid Volume Measurement. N/A
Active, not recruiting NCT05328076 - Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography
Not yet recruiting NCT06377943 - The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females
Recruiting NCT03933358 - Effect of Thyroid Hormone on Post-Myocardial Infarction Remodeling and Prognosis in STEMI Patients
Active, not recruiting NCT02681328 - Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules